Asio Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Asio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$15.39 - $18.97 $1.6 Million - $1.97 Million	-103,665 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$17.1 - $19.19 $128,848 - $144,596	7,535 Added 7.84%	103,665 $1.85 Million
Q2 2020 Jul 31, 2020	BUY	$14.59 - $19.5 $100,233 - $133,965	6,870 Added 7.7%	96,130 $1.72 Million
Q1 2020 Apr 28, 2020	BUY	$13.02 - $20.31 $81,023 - $126,389	6,223 Added 7.49%	89,260 $1.36 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $1.4 Million - $1.73 Million	83,037 New	83,037 $1.64 Million

336

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.3B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Asio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Asio Capital, LLC with notifications on news.